If adopted, the rules could impose significant new responsibilities on businesses that handle consumer data, including potentially barring certain kinds of data collection practices, the people said.


FBI's Trump Search Stirs Talk, Except by Those Who Conducted It

The FBI search of former President Donald Trump's Mar-a-Lago home Monday was unprecedented, prompting days of global news coverage and commentary on motivations, implications and ramifications.

Key players no one has heard from: the Justice Department or the Federal Bureau of Investigation.


Write to paul.larkins@dowjones.com TODAY IN CANADA

Earnings:

2Q unless stated otherwise

Algonquin Pwr & Utilities

Altus Grp Limited

Brookfield Asst Mgmnt

Canacol Energy

Canada Goose Hldgs (1Q)

Canadian Tire

CES Energy Solutions

CI Fincl

Cineplex

Computer Modelling (1Q)

Docebo

ECN Capital

Exchange Income

Farmers Edge

Fiera Capital

GCM Mining

Gogold Resources (4Q)

Guardian Capital

Hardwoods Distrib

HLS Therapeutics

Hut 8 Mining

IMV

Knight Therapeutics

KP Tissue

mdf commerce (1Q)

Mogo

Northland Power

Oncolytics Biotech

Park Lawn

Primo Water

Quarterhill

Sandstorm Gold

Shawcor

Sierra Metals

Sierra Wireless

Silvercorp Metals (1Q)

Tidewtr Midstrm & Infr

Tidewater Renewbls

Timbercreek Fincl

Vermilion Energy

WELL Health Tech

Wheaton Precs Mtls

Xebec Adsorption

Economic Indicators:

None scheduled

Stocks to Watch:

Africa Oil 2Q EPS 1c; Net $5.65M

---

AutoCanada 2Q EPS C$1.33; Net C$39.1M; Rev C$1.69M

---

Badger Infrastructure Solutions 2Q Rev $144.2M; EPS 14C

---

Enerflex 2Q EPS C$0.15; Net C$13.4M; Rev C$372.1M; Underlying Driver of Enerflex's Business Is the Demand for Natural Gas, the Outlook for Which Is Robust; Continued Growth of Liquefied Natural Gas Exports Off the US Gulf Coast and Need for Reliable Power Generation in Regions Like Latin Amer and the Middle East Present Strong Demand Fundamentals

---

Fortuna Silver Mines 2Q EPS 1c; Net $1.7M; Sales $167.9M; Inflation Situation Remains Dynamic and Company Expects Higher Input Costs to Remain for 2H of Yr and Beyond; To Mitigate Inflationary Pressure on Cost Structure the Co Will Continue to Focus on Operational Efficiencies and Cost Optimization Across All Mining Ops; Even With These Efforts It Is Expected the Continued Cost Pressure Will Push the San Jose and Lindero Mines Toward Upper End of Our Cost Guidance

---

Mandalay Resources 2Q Rev $50.1M; EPS 3C

---

Pan American Silver 2Q Rev $340.47B; Loss/Shr 83c

---

VIQ Solutions 2Q Loss/Shr 11c; Loss $3.2M; Rev $12.4M


Expected Major Events for Thursday

08:00/FRA: Aug IEA Oil Market Report

08:30/UK: 2Q Mortgage and landlord possession statistics

08:30/UK: 2Q Mortgage Arrears and Possessions data

12:30/US: Jul PPI

12:30/US: 08/06 Unemployment Insurance Weekly Claims Report - Initial Claims

12:30/US: U.S. Weekly Export Sales

13:00/RUS: Weekly International Reserves

14:30/US: 08/05 EIA Weekly Natural Gas Storage Report

16:59/GER: Jun Balance of Payments

20:30/US: Foreign Central Bank Holdings

20:30/US: Federal Discount Window Borrowings

All times in GMT. Powered by Onclusive and Dow Jones.


Expected Earnings for Thursday

Aravive Inc (ARAV) is expected to report $-0.59 for 2Q.

Axcella Health Inc (AXLA) is expected to report for 2Q.

Bellerophon Therapeutics Inc (BLPH) is expected to report for 2Q.

CI Financial Corp (CIFAF,CIX.T) is expected to report $0.74 for 2Q.

Cabaletta Bio Inc (CABA) is expected to report for 2Q.

Cardinal Health Inc (CAH) is expected to report $0.77 for 4Q.

Catalyst Biosciences Inc (CBIO) is expected to report $-0.25 for 2Q.

Computer Modelling Group is expected to report $0.05 for 1Q.

CorEnergy Infrastructure Trust Inc (CORR) is expected to report for 2Q.

Dentsply Sirona Inc (XRAY) is expected to report $0.39 for 2Q.

Evelo Biosciences Inc (EVLO) is expected to report $-0.51 for 2Q.

Fulcrum Therapeutics Inc (FULC) is expected to report for 2Q.

Golden Minerals (AUMN,AUMN.T) is expected to report for 2Q.

HLS Therapeutics is expected to report for 2Q.

Hanesbrands Inc (HBI) is expected to report $0.32 for 2Q.

Hudson Global Inc (HSON) is expected to report for 2Q.

Kala Pharmaceuticals Inc (KALA) is expected to report $-0.39 for 2Q.

La Jolla Pharmaceutical (LJPC) is expected to report $-1.04 for 2Q.

Latham Group Inc (SWIM) is expected to report for 2Q.

Liquidia Corp (LQDA) is expected to report $-0.24 for 2Q.

Luna Innovations (LUNA) is expected to report $0.00 for 2Q.

Marinus Pharmaceuticals Inc (MRNS) is expected to report for 2Q.

Matinas BioPharma Holdings Inc (MTNB) is expected to report $-0.03 for 2Q.

McEwen Mining (MUX,MUX.T) is expected to report for 2Q.

ModivCare Inc (MODV) is expected to report for 2Q.

Neonode (NEON) is expected to report for 2Q.

ONEX Corp (Canada) (ONEX.T) is expected to report for 2Q.

Oncolytics Biotech Inc (ONC.T,ONCY) is expected to report $-0.11 for 2Q.

OptiNose Inc (OPTN) is expected to report $-0.24 for 2Q.

Orgenesis Inc (ORGS) is expected to report $-0.02 for 2Q.

Primo Water Corp (PRMW,PRMW.T) is expected to report for 2Q.

Privia Health Group Inc (PRVA) is expected to report for 2Q.

Quarterhill Inc (QTRH,QTRH.T) is expected to report $-0.01 for 2Q.

RGC Resources Inc (RGCO) is expected to report $0.48 for 3Q.

ReShape Lifesciences Inc (RSLS) is expected to report for 2Q.

Rogers Sugar (RSGUF,RSI.T) is expected to report for 3Q.

Six Flags Entertainment Corp (SIX) is expected to report $1.02 for 2Q.

Synthetic Biologics Inc (SYN) is expected to report for 2Q.

US Foods Holding Corp (USFD) is expected to report $0.57 for 2Q.

UroGen Pharma Ltd (URGN) is expected to report $-1.34 for 2Q.

Powered by Onclusive and Dow Jones.


ANALYST RATINGS ACTIONS

Allbirds Cut to Equal-Weight From Overweight by Morgan Stanley

Allogene Therapeutics Cut to Market Perform From Outperform by Raymond James

Altice USA Cut to Hold From Buy by HSBC

Amyris Cut to Neutral From Buy by Roth Capital

Berkeley Lights Cut to Neutral From Buy by BTIG

Berkeley Lights Cut to Neutral From Overweight by JP Morgan

Berkeley Lights Cut to Underweight From Equal-Weight by Morgan Stanley

BigBear.ai Cut to Perform From Outperform by Oppenheimer

Boxed Cut to Neutral From Buy by Citigroup

Cerence Cut to Hold From Buy by Craig-Hallum

Cerence Cut to Market Perform From Outperform by Raymond James

CF Industries Raised to Overweight From Equal-Weight by Barclays

ChemoCentryx Cut to Hold From Buy by Stifel

Coinbase Cut to Underperform From Market Perform by Keefe, Bruyette & Woods

Emcore Cut to Market Perform From Outperform by Northland Capital Markets

Energizer Holdings Cut to Equal-Weight From Overweight by Morgan Stanley

Equitrans Midstream Raised to Overweight From Equal-Weight by Wells Fargo

iHeartMedia Cut to Neutral From Buy by Goldman Sachs

Invitae Cut to Underweight From Neutral by JP Morgan

LivePerson Cut to Hold From Buy by Loop Capital

Micron Technology Cut to Outperform From Strong Buy by Raymond James

Minerva Surgical Cut to Underweight From Overweight by JP Morgan

Moody's Cut to Hold From Buy by Deutsche Bank

Okta Cut to Neutral From Buy by DA Davidson

Par Technology Cut to Hold From Buy by Jefferies

Quotient Technology Cut to Hold From Buy by Craig-Hallum

Rackspace Technology Cut to Market Perform From Outperform by Raymond James

RealReal Cut to Underperform From Buy by B of A Securities

Repay Holdings Cut to Neutral From Buy by Citigroup

Roku Cut to Underperform From Market Perform by MoffettNathanson

ShotSpotter Raised to Buy From Hold by Lake Street

Singular Genomics Shares Slide as Supply-Chain Woes crimp Shipments

Singular Genomics Systems Cut to Neutral From Buy by Goldman Sachs

Singular Genomics Systems Cut to Underperform From Buy by B of A Securities

Take-Two Interactive Cut to Hold From Buy by DZ Bank

TaskUs Cut to Neutral From Buy by Goldman Sachs

UWM Holdings Cut to Underperform From Neutral by Credit Suisse

V2X Raised to Buy From Hold by Stifel

Vertex Energy Cut to Perform From Outperform by Oppenheimer

WM Technology Cut to Hold From Buy by Stifel

WM Technology Cut to Neutral From Buy by BTIG

WM Technology Cut to Neutral From Overweight by Piper Sandler

Workhorse Group Cut to Neutral From Buy by Roth Capital

This article is a text version of a Wall Street Journal newsletter published earlier today.


(END) Dow Jones Newswires

08-11-22 0532ET